Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cahn

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Therapeutique (La Semaine Des Hopitaux)|October 1, 1970
[Modifications of hepatocyte membranes permeability secondary to any hepatic agression. Enzymatic repercussions and therapeutic consequences]J Cahn
Minerva Medica|May 19, 1976
[Current problems in the pharmacotherapy of vascular diseases]J Cahn
Medizinische Klinik|October 24, 1979
[Pathopharmacologic models of cerebral disorders]J Cahn
Managed Care (Langhorne, Pa.)|October 12, 2010
When is a brand a generic? In a contract with a PBMLinda J Cahn
Managed Care (Langhorne, Pa.)|December 15, 2010
Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugsLinda J Cahn
Managed Care (Langhorne, Pa.)|September 8, 2009
Control specialty drug cost by making your PBM helpfulLinda J Cahn
Managed Care (Langhorne, Pa.)|February 4, 2009
Don't get trapped by PBMs' rebate labeling gamesLinda J Cahn
Managed Care (Langhorne, Pa.)|October 9, 2008
Don't get caught by PBMs' MAC mousetrapsLinda J Cahn
Archives of Dermatology|January 1, 1972
Hypomelanosis from an antioxidant in polyethylene firmB J Cahn
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
A shared-care approach to the management of patients with mHSPC: the urology perspectiveDavid J Cahn
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Therapeutique (La Semaine Des Hopitaux)|October 1, 1970
[Modifications of hepatocyte membranes permeability secondary to any hepatic agression. Enzymatic repercussions and therapeutic consequences]J Cahn
Minerva Medica|May 19, 1976
[Current problems in the pharmacotherapy of vascular diseases]J Cahn
Medizinische Klinik|October 24, 1979
[Pathopharmacologic models of cerebral disorders]J Cahn
Managed Care (Langhorne, Pa.)|October 12, 2010
When is a brand a generic? In a contract with a PBMLinda J Cahn
Managed Care (Langhorne, Pa.)|December 15, 2010
Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugsLinda J Cahn
Managed Care (Langhorne, Pa.)|September 8, 2009
Control specialty drug cost by making your PBM helpfulLinda J Cahn
Managed Care (Langhorne, Pa.)|February 4, 2009
Don't get trapped by PBMs' rebate labeling gamesLinda J Cahn
Managed Care (Langhorne, Pa.)|October 9, 2008
Don't get caught by PBMs' MAC mousetrapsLinda J Cahn
Archives of Dermatology|January 1, 1972
Hypomelanosis from an antioxidant in polyethylene firmB J Cahn
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
A shared-care approach to the management of patients with mHSPC: the urology perspectiveDavid J Cahn
Pageof 7